Valemetostat Tosylate (DS-3201b)

valemetostat tosylate · Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valemetostat Tosylate (DS-3201b), covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma [Phase 2]